Skip to content

Clinical trials

Essential Hypertension trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Essential Hypertension Country / region: Germany Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20032
20053
20063
20074
20085
20093
20103
20112
20121
20151
20161
20182
20191
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Active, not recruiting2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis6
Sankyo Pharma Gmbh6
Daiichi Sankyo4
Takeda3
University of Erlangen-Nürnberg Medical School3
Bayer2
Novartis Pharmaceuticals2
ReCor Medical, Inc.2
Abbott1
Ablative Solutions, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Essential Hypertension35
Hypertension15
Vascular Diseases4
Cardiovascular Diseases3
Atherosclerosis1
Dizziness1
Edema1
Heart Failure1
Hypercholesterolemia1
Hypertrophy, Left Ventricular1

Trials

Showing 76 to 35 of 35. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.